Literature DB >> 15537904

Cytokine-based therapies for Crohn's disease--new paradigms.

Fabio Cominelli1.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15537904     DOI: 10.1056/NEJMp048253

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  30 in total

1.  Tumor necrosis factor-α represses the expression of NHE2 through NF-κB activation in intestinal epithelial cell model, C2BBe1.

Authors:  Md Ruhul Amin; Temitope Orenuga; Sangeeta Tyagi; Pradeep K Dudeja; Krishnamurthy Ramaswamy; Jaleh Malakooti
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

2.  Distinctive pattern of cytokine production and adhesion molecule expression in peripheral blood memory CD4+ T cells from patients with active Crohn's disease.

Authors:  Jaime García de Tena; Luis Manzano; Juan Carlos Leal; Esther San Antonio; Verónica Sualdea; Melchor Alvarez-Mon
Journal:  J Clin Immunol       Date:  2006-05-02       Impact factor: 8.317

3.  Role of interleukin 6 in a murine model of Crohn's ileitis: are cytokine/anticytokine strategies the future for IBD therapies?

Authors:  T T Pizarro; S A De La Rue; F Cominelli
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

4.  Probiotics and ileitis: could augmentation of TNF/NFκB activity be the answer?

Authors:  Christian Jobin
Journal:  Gut Microbes       Date:  2010-05-26

5.  Functional defects in NOD2 signaling in experimental and human Crohn disease.

Authors:  Daniele Corridoni; Kristen O Arseneau; Fabio Cominelli
Journal:  Gut Microbes       Date:  2014-03-05

6.  Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis.

Authors:  Luca Pastorelli; Rekha R Garg; Sharon B Hoang; Luisa Spina; Benedetta Mattioli; Melania Scarpa; Claudio Fiocchi; Maurizio Vecchi; Theresa T Pizarro
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 7.  Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.

Authors:  Guillaume Bouguen; Jean-Baptiste Chevaux; Laurent Peyrin-Biroulet
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

8.  Certolizumab pegol for the treatment of Crohn's disease.

Authors:  Stefan Schreiber
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

9.  Downregulation of sodium transporters and NHERF proteins in IBD patients and mouse colitis models: potential contributors to IBD-associated diarrhea.

Authors:  Sean Sullivan; Philip Alex; Themos Dassopoulos; Nicholas C Zachos; Christine Iacobuzio-Donahue; Mark Donowitz; Steven R Brant; Carmen Cuffari; Mary L Harris; Lisa Wu Datta; Laurie Conklin; Yueping Chen; Xuhang Li
Journal:  Inflamm Bowel Dis       Date:  2009-02       Impact factor: 5.325

Review 10.  Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.

Authors:  Rita Del Pinto; Davide Pietropaoli; Apoorva K Chandar; Claudio Ferri; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.